Published in Arthritis Rheumatol on March 28, 2017
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature (2015) 3.06
A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med (2010) 2.88
Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med (2015) 2.70
Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol (2014) 2.58
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma. N Engl J Med (2015) 2.39
Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages. Cell (2016) 2.12
The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry. Arthritis Rheumatol (2014) 1.83
In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire. Nat Med (2014) 1.81
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science (2016) 1.72
Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses. Blood (2014) 1.65
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol (2006) 1.60
Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proc Natl Acad Sci U S A (2012) 1.60
A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J Immunol (2003) 1.59
A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus. Immunity (2016) 1.59
Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus. Immunity (2015) 1.58
Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant (2013) 1.53
Prolonged clinical remission in patients with systemic lupus erythematosus. J Rheumatol (2014) 1.48
Apoptosis in response to microbial infection induces autoreactive TH17 cells. Nat Immunol (2016) 1.47
Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med (2016) 1.45
Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J Exp Med (2014) 1.44
Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet (2015) 1.42
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature (2015) 1.42
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials. Arthritis Rheumatol (2017) 1.40
Type I interferonopathies: mendelian type I interferon up-regulation. Curr Opin Immunol (2014) 1.37
Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow. Immunity (2015) 1.27
SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One (2013) 1.25
B10 cells: a functionally defined regulatory B cell subset. J Immunol (2015) 1.22
Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol (2015) 1.20
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response. Immunity (2015) 1.17
Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc Natl Acad Sci U S A (2014) 1.16
Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J Immunol (2011) 1.16
Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med (2014) 1.14
Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum (2007) 1.09
The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis? Curr Opin Rheumatol (2014) 1.08
TREG-cell therapies for autoimmune rheumatic diseases. Nat Rev Rheumatol (2014) 1.06
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. Cell (2016) 1.05
Cutting Edge: DNase II deficiency prevents activation of autoreactive B cells by double-stranded DNA endogenous ligands. J Immunol (2015) 0.98
Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity. Cell (2016) 0.93
Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J Exp Med (2016) 0.93
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. Elife (2016) 0.93
Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway. Clin Transl Immunology (2016) 0.93
The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression. Science (2015) 0.92
Adaptive Designs for Clinical Trials. N Engl J Med (2016) 0.90
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE. Lupus Sci Med (2015) 0.89
Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. Ann Rheum Dis (2016) 0.87
PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Cancer Discov (2016) 0.87
Manipulation of B-cell responses with histone deacetylase inhibitors. Nat Commun (2015) 0.86
Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis. Arthritis Rheumatol (2016) 0.86
Multiplexed, targeted profiling of single-cell proteomes and transcriptomes in a single reaction. Genome Biol (2016) 0.86
What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol (2015) 0.84
TFH cells progressively differentiate to regulate the germinal center response. Nat Immunol (2016) 0.84
Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev (2014) 0.84
Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity. Arthritis Rheumatol (2016) 0.84
Remission in systemic lupus erythematosus: durable remission is rare. Ann Rheum Dis (2016) 0.84
Human plasma cells express granzyme B. Eur J Immunol (2013) 0.81
A critical review of clinical trials in systemic lupus erythematosus. Lupus (2016) 0.81
Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys. Nat Rev Rheumatol (2013) 0.81
Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people, 2007-2009. Arthritis Rheumatol (2014) 0.81
Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep (2016) 0.81
Update on clinical trials in systemic lupus erythematosus. Curr Opin Rheumatol (2016) 0.80
The applied basic research of systemic lupus erythematosus based on the biological omics. Genes Immun (2013) 0.80
Low-Dose IL-2 in the Treatment of Lupus. Curr Rheumatol Rep (2016) 0.80
ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in naïve SLE B cells. Sci Rep (2016) 0.79
Analysis of Complete Remission in Systemic Lupus Erythematosus Patients Over a 32-Year Period. Arthritis Care Res (Hoboken) (2016) 0.79
Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non-Th1 Effector T Cell Immune Response as an Early Event in Lupus Flares. Arthritis Rheumatol (2016) 0.79
Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity. Annu Rev Med (2015) 0.78
Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us? Nat Rev Rheumatol (2016) 0.78
Bruton's Tyrosine Kinase Deficiency Inhibits Autoimmune Arthritis in Mice but Fails to Block Immune Complex-Mediated Inflammatory Arthritis. Arthritis Rheumatol (2016) 0.78
SLE-associated risk factors affect DC function. Immunol Rev (2016) 0.78
T cells in Systemic Lupus Erythematosus. Curr Opin Immunol (2016) 0.78
The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol (2016) 0.77
Interferon-targeted therapy in systemic lupus erythematosus: Is this an alternative to targeting B and T cells? Lupus (2016) 0.77
Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus. Clin Immunol (2016) 0.76
Editorial: A Stalemate in Lupus-Related End-Stage Renal Disease: Can We Do Better? Arthritis Rheumatol (2016) 0.76
Therapeutic Blockade of Immune Complex-Mediated Glomerulonephritis by Highly Selective Inhibition of Bruton's Tyrosine Kinase. Sci Rep (2016) 0.76
Network Analysis Identifies Proinflammatory Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity. J Immunol (2016) 0.76
MEDI-551 Treatment Effectively Depletes B Cells and Reduces Serum Titers of Autoantibodies in Mice Transgenic for Sle1 and Human CD19. Arthritis Rheumatol (2016) 0.76
Lupus in Latin-American patients: lessons from the GLADEL cohort. Lupus (2015) 0.76
Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis. Lupus (2016) 0.75
Why targeted therapies are necessary for systemic lupus erythematosus. Lupus (2016) 0.75
The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned. J Autoimmun (2016) 0.75
Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE. Nat Rev Rheumatol (2016) 0.75
In Praise of Descriptive Science: A Breath of Fresh AIRE. Cell (2016) 0.75
A systems approach to renal inflammation in SLE. Clin Immunol (2016) 0.75
Autoimmunity: Interferon α or β: which is the culprit in autoimmune disease? Nat Rev Rheumatol (2016) 0.75